Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related virusesRyo Shinnakasu, Tomohiro Kurosaki, Shuhei Sakakibara et al.|The Journal of Experimental Medicine|2021Cited by 34
Relationships between types of adenovirus indicated by heterologous neutralization.Shigeharu Uchida, Akemi Furuno, Satoshi Koseki et al.|PubMed|1959Cited by 11